The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpectra (di/ S) Regulatory News (SPSC)

Share Price Information for Spectra (di/ S) (SPSC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 260.00
Bid: 220.00
Ask: 300.00
Change: 0.00 (0.00%)
Spread: 80.00 (36.364%)
Open: 260.00
High: 260.00
Low: 260.00
Prev. Close: 260.00
SPSC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of Chief Financial Officer

23 Jan 2017 07:00

RNS Number : 7780U
Spectra Systems Corporation
23 January 2017
 

Spectra Systems Corporation

("The Company" or "Spectra Systems")

Appointment of Chief Financial Officer

Spectra Systems, a leading supplier of authentication technology for banknotes, brand authentication and tax stamps, is delighted to announce that, subject to the satisfactory conclusion of due diligence, it has agreed to appoint Brian E McLain C.P.A. (aged 41) as its new Chief Financial Officer.

Brian McLain started his career in 1997 at Arthur Andersen prior to working as a senior accountant at Excelergy Corporation, a software business, located in Lexington, MA from 2000 until 2003. Until late 2006, he then progressed through various roles at International Power, a UK owned power producer located in Marlborough MA, prior to joining SeraCare Life Sciences, Inc, a manufacturer of biological products for the diagnostics and drug discovery markets located in Milford MA. At SeraCare, which was quoted on NASDAQ prior to being bought out in 2012, he progressed from the role of Corporate Controller to Vice President, Finance & Business Solutions. In 2014, he then joined OMNIlife Science Inc., a manufacturer and distributor of orthopaedic devices located in Raynham, MA, in the role of Corporate Controller.

A further announcement will be made upon the conclusion of due diligence by certain of Spectra's customers and the completion of standard regulatory AIM background checks. This due diligence is expected to be completed by no later than February 2017. In the meantime, Doug Anderson, the previous Chief Financial Officer is continuing to assist Spectra as necessary.

Brian McLain joined SeraCare Life Sciences Inc. ("SeraCare") in January 2007, at which point it was already in a bankruptcy process. All creditors were subsequently settled and SeraCare exited the bankruptcy process. There are no other matters which are required to be announced pursuant to paragraph (g) of Schedule 2 to the AIM Rules.

This announcement contains inside information for the purposes of Article 7 of Regulation 596/2014.

Dr. Nabil Lawandy, CEO of Spectra Systems, stated: "I am delighted to welcome Brian to Spectra Systems and believe that his extensive financial experience in both private and public businesses as well as his experience in technology driven companies will be of immense value to us."

Enquiries:

Spectra Systems Corporation

Dr. Nabil Lawandy, Chief Executive Officer Tel: +1 (0) 401 274 4700

WH Ireland Limited

Chris Fielding (Head of Corporate Finance) Tel: +44 (0) 20 7220 1650

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSEFFWSFWSEFF
Date   Source Headline
19th Dec 20088:00 amRNSNet Asset Value(s)
18th Dec 20087:49 amRNSNet Asset Value(s)
17th Dec 20087:42 amRNSNet Asset Value(s)
16th Dec 20087:37 amRNSNet Asset Value(s)
15th Dec 20087:38 amRNSNet Asset Value(s)
12th Dec 20087:36 amRNSNet Asset Value(s)
11th Dec 20087:41 amRNSNet Asset Value(s)
10th Dec 20087:38 amRNSNet Asset Value(s)
9th Dec 20087:40 amRNSNet Asset Value(s)
8th Dec 20087:59 amRNSNet Asset Value(s)
5th Dec 20087:39 amRNSNet Asset Value(s)
4th Dec 20087:33 amRNSNet Asset Value(s)
3rd Dec 20087:43 amRNSNet Asset Value(s)
2nd Dec 20088:33 amRNSNet Asset Value(s)
1st Dec 20089:00 amRNSNet Asset Value(s)
27th Nov 20087:56 amRNSNet Asset Value(s)
26th Nov 20087:46 amRNSNet Asset Value(s)
25th Nov 20088:22 amRNSNet Asset Value(s)
24th Nov 20088:16 amRNSNet Asset Value(s)
21st Nov 20087:40 amRNSNet Asset Value(s)
20th Nov 20087:41 amRNSNet Asset Value(s)
19th Nov 20087:37 amRNSNet Asset Value(s)
18th Nov 20087:42 amRNSNet Asset Value(s)
17th Nov 20088:21 amRNSNet Asset Value(s)
14th Nov 20087:58 amRNSNet Asset Value(s)
13th Nov 20087:53 amRNSNet Asset Value(s)
12th Nov 20088:01 amRNSNet Asset Value(s)
11th Nov 20087:59 amRNSNet Asset Value(s)
10th Nov 20088:08 amRNSNet Asset Value(s)
7th Nov 20087:42 amRNSNet Asset Value(s)
6th Nov 20087:50 amRNSNet Asset Value(s)
5th Nov 20087:51 amRNSNet Asset Value(s)
4th Nov 20088:03 amRNSNet Asset Value(s)
3rd Nov 20088:20 amRNSNet Asset Value(s)
31st Oct 20087:59 amRNSNet Asset Value(s)
30th Oct 20088:09 amRNSNet Asset Value(s)
29th Oct 20087:38 amRNSNet Asset Value(s)
28th Oct 20087:55 amRNSNet Asset Value(s)
27th Oct 20087:35 amRNSNet Asset Value(s)
24th Oct 20087:20 amRNSNet Asset Value(s)
23rd Oct 20087:35 amRNSNet Asset Value(s)
22nd Oct 20087:38 amRNSNet Asset Value(s)
21st Oct 20088:05 amRNSNet Asset Value(s)
20th Oct 20087:39 amRNSNet Asset Value(s)
17th Oct 20087:25 amRNSNet Asset Value(s)
16th Oct 20087:52 amRNSNet Asset Value(s)
15th Oct 20089:50 amRNSNet Asset Value(s)
14th Oct 20087:46 amRNSNet Asset Value(s)
13th Oct 20088:18 amRNSNet Asset Value(s)
10th Oct 20087:24 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.